EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 62018TN0321
Case T-321/18: Action brought on 18 May 2018 — Serenity Pharmaceuticals v EUIPO — Gebro Holding (NOCUVANT)
Case T-321/18: Action brought on 18 May 2018 — Serenity Pharmaceuticals v EUIPO — Gebro Holding (NOCUVANT)
Case T-321/18: Action brought on 18 May 2018 — Serenity Pharmaceuticals v EUIPO — Gebro Holding (NOCUVANT)
OJ C 240, 9.7.2018, p. 61–61
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
Case T-321/18: Action brought on 18 May 2018 — Serenity Pharmaceuticals v EUIPO — Gebro Holding (NOCUVANT)
Action brought on 18 May 2018 — Serenity Pharmaceuticals v EUIPO — Gebro Holding (NOCUVANT)
(Case T-321/18)
2018/C 240/70Language in which the application was lodged: EnglishParties
Applicant: Serenity Pharmaceuticals LLC (Milford, Pennsylvania, United States) (represented by: J. Day, Solicitor)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Gebro Holding GmbH (Fieberbrunn, Austria)
Details of the proceedings before EUIPO
Applicant of the trade mark at issue: Applicant
Trade mark at issue: EU word mark NOCUVANT — Application for registration No 13 053 434
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the Second Board of Appeal of EUIPO of 8 March 2018 in Case R 584/2017-2
Form of order sought
The applicant claims that the Court should:
|
— |
annul the contested decision; |
|
— |
annul the decision of the Opposition Division of 27 January 2018 in Opposition No. B 002437922; |
|
— |
order EUIPO and Gebro Holdings GmbH to bear their own costs and pay those of the Applicant. |
Pleas in law
|
— |
Infringement of Article 47(2) of Regulation No 2017/1001; |
|
— |
Infringement of Article 8(1)(b) of Regulation No 2017/1001. |